AJGP
HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a Colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trappler, B.
Right arrow Articles by Cohen, C. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trappler, B.
Right arrow Articles by Cohen, C. I.
Am J Geriatr Psychiatry 6:83-89, February 1998
© 1998 American Association for Geriatric Psychiatry


Clinical and Research Report

Use of SSRIs in "Very Old" Depressed Nursing Home Residents

Brian Trappler, M.D., and Carl I. Cohen, M.D.

Received December 26, 1996; revised May 26, 1997; accepted June 26, 1997. From the SUNY Health Science Center at Brooklyn. Address correspondence to Dr. Trappler, SUNY Health Science Center at Brooklyn, Box 1203, 450 Clarkson Avenue, Brooklyn, NY 11203.

The authors examined 50 patients, with a mean age of 89 years (range: 80–98), placed in a prospective, open-label trial of either fluoxetine, sertraline, or paroxetine. At 12-week follow-up, there was a significant overall decline (36%) in Ham-D scores; 42% had at least a 50% decline in their scores. There were no significant differences in responses to the three antidepressants, and all drugs were well tolerated. However, there were significant differences between diagnostic subgroups in the percentage of persons showing at least a 50% decrease in their Ham-D scores: major depressive disorder (MDD; 93%), Alzheimer's disease with MDD (8%), vascular dementia with MDD (6%), and other CNS-related disorders with MDD (83%). The findings confirm earlier accounts that antidepressants may be substantially less effective with MDD secondary to dementia in very old patients.

Key Words: SSRIs • Inpatients • Geriatric Depression




This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
S. P. Roose, H. A. Sackeim, K. R. R. Krishnan, B. G. Pollock, G. Alexopoulos, H. Lavretsky, I. R. Katz, H. Hakkarainen, and Old-Old Depression Study Group
Antidepressant Pharmacotherapy in the Treatment of Depression in the Very Old: A Randomized, Placebo-Controlled Trial
Am J Psychiatry, November 1, 2004; 161(11): 2050 - 2059.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
D. W. Oslin, J. E. Streim, I. R. Katz, B. D. Smith, S. D. DiFilippo, T. R. Ten Have, and T. Cooper
Heuristic Comparison of Sertraline With Nortriptyline for the Treatment of Depression in Frail Elderly Patients
Am J Geriatr Psychiatry, May 1, 2000; 8(2): 141 - 149.
[Abstract] [Full Text]


Home page
AJGPHome page
J. E. Streim, D. W. Oslin, I. R. Katz, B. D. Smith, S. DiFilippo, T. B. Cooper, and T. Ten Have
Drug Treatment of Depression in Frail Elderly Nursing Home Residents
Am J Geriatr Psychiatry, May 1, 2000; 8(2): 150 - 159.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
Copyright © 1998 American Association for Geriatric Psychiatry